The AI denial fighters and health care’s rising profitability

This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here.

Using AI appeals for AI denials

Health insurance companies are using artificial intelligence to automate care denials, and now patients and entrepreneurs are fighting back using that same technology, my colleague Casey Ross reports.

Holden Karau created FightHealthInsurance.com to help patients and doctors fight insurance denials, after her insurer, UnitedHealthcare, wouldn’t cover her physical therapy. Karau’s product, which is open source and free, first asks patients to upload a denial letter and fill in other details. Then the AI tool drafts appeal letters, which patients can choose and edit before firing off to their insurer.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Lawmakers call for US investigation of Chinese contract research giants

Four bipartisan lawmakers have urged the US government to investigate contract research and manufacturing giants WuXi AppTec and WuXi Biologics for alleged Chinese military ties.

February 14, 2024

Key congressman blasts HHS for lack of cooperation on Covid-19

The Health and Human Services Department’s lack of cooperation with a congressional committee investigating the Covid-19 pandemic is “unacceptable” and could prompt the committee to

February 16, 2024

Orasis gains FDA approval for presbyopia eye drops, following in AbbVie’s footsteps

Orasis Pharmaceuticals has secured approval in the US for its age-related blurry vision eye drops, marking the second time the FDA has greenlit a presbyopia

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.